Viewing Study NCT00476112


Ignite Creation Date: 2025-12-26 @ 11:13 PM
Ignite Modification Date: 2025-12-26 @ 11:13 PM
Study NCT ID: NCT00476112
Status: COMPLETED
Last Update Posted: 2008-04-02
First Post: 2007-05-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter
Sponsor: Advanz Pharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module